Drug
Glatiramer Acetate Injection
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Multiple Sclerosis | 592 | 56.3 | 64.3 | signal |
| 2 | Injection Site Mass | 348 | 43.0 | 46.4 | signal |
| 3 | Multiple Sclerosis Relapse | 509 | 33.5 | 37.5 | signal |
| 4 | Injection Site Induration | 70 | 24.5 | 24.9 | signal |
| 5 | Injection Site Urticaria | 128 | 23.9 | 24.6 | signal |
| 6 | Injection Site Swelling | 290 | 17.3 | 18.4 | signal |
| 7 | Injection Site Pruritus | 244 | 16.6 | 17.5 | signal |
| 8 | Injection Site Warmth | 73 | 16.0 | 16.3 | signal |
| 9 | Injection Site Discolouration | 42 | 15.3 | 15.5 | signal |
| 10 | Injection Site Erythema | 389 | 14.3 | 15.5 | signal |
| 11 | Injection Site Extravasation | 37 | 13.4 | 13.5 | signal |
| 12 | Injection Site Irritation | 33 | 11.8 | 11.9 | signal |
| 13 | Injection Site Discomfort | 25 | 11.0 | 11.0 | signal |
| 14 | Injection Site Reaction | 162 | 10.7 | 11.0 | signal |
| 15 | Injection Site Pain | 715 | 10.7 | 12.4 | signal |
| 16 | Injection Site Bruising | 182 | 10.4 | 10.8 | signal |
| 17 | Device Use Issue | 39 | 10.2 | 10.3 | signal |
| 18 | Device Mechanical Issue | 29 | 10.2 | 10.2 | signal |
| 19 | Injection Site Nodule | 23 | 9.5 | 9.5 | signal |
| 20 | Needle Issue | 58 | 9.2 | 9.3 | signal |
| 21 | Central Nervous System Lesion | 27 | 8.8 | 8.9 | signal |
| 22 | Product Substitution Issue | 94 | 7.4 | 7.5 | signal |
| 23 | Pharyngeal Swelling | 15 | 7.1 | 7.1 | signal |
| 24 | Lymphopenia | 21 | 6.7 | 6.8 | signal |
| 25 | Injection Site Haemorrhage | 118 | 6.7 | 6.9 | signal |
| 26 | Flushing | 147 | 6.5 | 6.7 | signal |
| 27 | Hemiparesis | 23 | 6.1 | 6.1 | signal |
| 28 | Product Dose Omission | 88 | 6.0 | 6.1 | signal |
| 29 | Injection Site Rash | 37 | 5.5 | 5.5 | signal |
| 30 | Incorrect Route Of Product Administration | 20 | 5.4 | 5.4 | signal |
| 31 | Feeling Hot | 72 | 5.3 | 5.4 | signal |
| 32 | Hypoaesthesia | 173 | 5.2 | 5.4 | signal |
| 33 | Diplopia | 29 | 5.0 | 5.1 | signal |
| 34 | Device Issue | 95 | 4.9 | 5.0 | signal |
| 35 | Abortion Induced | 10 | 4.8 | 4.8 | signal |
| 36 | Maternal Exposure During Pregnancy | 93 | 4.8 | 4.8 | signal |
| 37 | Chills | 123 | 4.7 | 4.8 | signal |
| 38 | Paralysis | 15 | 4.7 | 4.7 | signal |
| 39 | Anaphylactic Shock | 26 | 4.6 | 4.6 | signal |
| 40 | Chest Discomfort | 100 | 4.4 | 4.5 | signal |
| 41 | Syringe Issue | 17 | 4.4 | 4.4 | signal |
| 42 | Muscle Spasticity | 12 | 4.4 | 4.4 | signal |
| 43 | Feeling Cold | 26 | 4.2 | 4.2 | signal |
| 44 | Limb Discomfort | 28 | 4.1 | 4.1 | signal |
| 45 | Throat Tightness | 24 | 4.0 | 4.0 | signal |
| 46 | Scar | 15 | 3.9 | 4.0 | signal |
| 47 | Hypoaesthesia Oral | 13 | 3.9 | 3.9 | signal |
| 48 | Product Packaging Issue | 8 | 3.9 | 3.9 | signal |
| 49 | Skin Reaction | 12 | 3.9 | 3.9 | signal |
| 50 | Head Discomfort | 15 | 3.8 | 3.9 | signal |
| 51 | Injury Associated With Device | 17 | 3.8 | 3.8 | signal |
| 52 | Abortion Spontaneous | 34 | 3.8 | 3.8 | signal |
| 53 | Product Use Complaint | 13 | 3.8 | 3.8 | signal |
| 54 | Gait Inability | 27 | 3.7 | 3.7 | signal |
| 55 | Urinary Incontinence | 24 | 3.7 | 3.7 | signal |
| 56 | Insurance Issue | 12 | 3.6 | 3.7 | signal |
| 57 | Bladder Disorder | 8 | 3.6 | 3.6 | signal |
| 58 | Palpitations | 92 | 3.6 | 3.6 | signal |
| 59 | Therapy Interrupted | 54 | 3.5 | 3.6 | signal |
| 60 | Gait Disturbance | 147 | 3.5 | 3.5 | signal |
| 61 | Kidney Infection | 15 | 3.5 | 3.5 | signal |
| 62 | Ataxia | 9 | 3.4 | 3.4 | signal |
| 63 | Drug-induced Liver Injury | 23 | 3.4 | 3.4 | signal |
| 64 | Device Defective | 12 | 3.3 | 3.4 | signal |
| 65 | Device Failure | 11 | 3.3 | 3.3 | signal |
| 66 | Muscular Weakness | 81 | 3.2 | 3.3 | signal |
| 67 | Balance Disorder | 61 | 3.2 | 3.2 | signal |
| 68 | Paraesthesia | 110 | 3.1 | 3.2 | signal |
| 69 | Anaphylactic Reaction | 38 | 3.1 | 3.1 | signal |
| 70 | Muscle Tightness | 11 | 3.1 | 3.1 | signal |
| 71 | Product Dose Omission Issue | 193 | 3.1 | 3.1 | signal |
| 72 | Malignant Melanoma | 9 | 3.0 | 3.0 | signal |
| 73 | Clostridium Difficile Colitis | 7 | 3.0 | 3.0 | signal |
| 74 | Loss Of Consciousness | 81 | 2.9 | 2.9 | signal |
| 75 | Cystitis | 20 | 2.8 | 2.8 | signal |
| 76 | Tremor | 103 | 2.8 | 2.8 | signal |
| 77 | Neuralgia | 15 | 2.8 | 2.8 | signal |
| 78 | Micturition Urgency | 7 | 2.8 | 2.8 | signal |
| 79 | Speech Disorder | 32 | 2.8 | 2.8 | signal |
| 80 | Hepatomegaly | 6 | 2.7 | 2.7 | signal |
| 81 | Urticaria | 101 | 2.7 | 2.8 | signal |
| 82 | Therapy Cessation | 31 | 2.7 | 2.8 | signal |
| 83 | Adverse Reaction | 8 | 2.7 | 2.7 | signal |
| 84 | Hypotonia | 6 | 2.7 | 2.7 | signal |
| 85 | Aphasia | 18 | 2.7 | 2.7 | signal |
| 86 | Body Temperature Increased | 12 | 2.6 | 2.7 | signal |
| 87 | Ear Discomfort | 6 | 2.6 | 2.6 | signal |
| 88 | Ankle Fracture | 9 | 2.6 | 2.6 | signal |
| 89 | Wrong Technique In Product Usage Process | 117 | 2.6 | 2.7 | signal |
| 90 | Oral Pain | 13 | 2.6 | 2.6 | signal |
| 91 | Panic Attack | 21 | 2.6 | 2.6 | signal |
| 92 | Post Procedural Complication | 11 | 2.6 | 2.6 | signal |
| 93 | Mouth Ulceration | 12 | 2.6 | 2.6 | signal |
| 94 | Visual Impairment | 69 | 2.5 | 2.6 | signal |
| 95 | Cognitive Disorder | 26 | 2.5 | 2.5 | signal |
| 96 | Hospitalisation | 85 | 2.5 | 2.5 | signal |
| 97 | Chest Pain | 103 | 2.5 | 2.5 | signal |
| 98 | Urinary Tract Infection | 93 | 2.5 | 2.5 | signal |
| 99 | Dysstasia | 16 | 2.5 | 2.5 | signal |
| 100 | Brain Neoplasm | 5 | 2.5 | 2.5 | no signal |
| 101 | Pregnancy | 11 | 2.5 | 2.5 | signal |
| 102 | Heart Rate Increased | 53 | 2.4 | 2.4 | signal |
| 103 | Burning Sensation | 37 | 2.4 | 2.4 | signal |
| 104 | Swelling Face | 34 | 2.4 | 2.4 | signal |
| 105 | Vasculitis | 6 | 2.3 | 2.3 | no signal |
| 106 | Spinal Pain | 6 | 2.3 | 2.3 | no signal |
| 107 | Incorrect Dose Administered By Device | 13 | 2.3 | 2.3 | signal |
| 108 | Cold Sweat | 9 | 2.3 | 2.3 | signal |
| 109 | Syncope | 51 | 2.3 | 2.3 | signal |
| 110 | Inability To Afford Medication | 5 | 2.3 | 2.3 | no signal |
| 111 | Head Injury | 16 | 2.3 | 2.3 | signal |
| 112 | Seizure | 58 | 2.3 | 2.3 | signal |
| 113 | Covid-19 | 89 | 2.3 | 2.3 | signal |
| 114 | Mass | 7 | 2.3 | 2.3 | no signal |
| 115 | Coordination Abnormal | 7 | 2.2 | 2.3 | no signal |
| 116 | Device Leakage | 21 | 2.2 | 2.2 | signal |
| 117 | Presyncope | 12 | 2.2 | 2.2 | signal |
| 118 | Motor Dysfunction | 5 | 2.2 | 2.2 | no signal |
| 119 | Temperature Intolerance | 5 | 2.2 | 2.2 | no signal |
| 120 | Fall | 162 | 2.2 | 2.2 | signal |
| 121 | Paraesthesia Oral | 7 | 2.2 | 2.2 | no signal |
| 122 | Influenza Like Illness | 40 | 2.2 | 2.2 | signal |
| 123 | Lymphadenopathy | 17 | 2.2 | 2.2 | signal |
| 124 | Injection Site Haematoma | 7 | 2.2 | 2.2 | no signal |
| 125 | Renal Pain | 5 | 2.1 | 2.1 | no signal |
| 126 | Movement Disorder | 15 | 2.1 | 2.1 | signal |
| 127 | Oral Herpes | 9 | 2.1 | 2.1 | signal |
| 128 | Ocular Discomfort | 5 | 2.1 | 2.1 | no signal |
| 129 | Product Quality Issue | 62 | 2.1 | 2.1 | signal |
| 130 | Device Difficult To Use | 30 | 2.0 | 2.1 | signal |
| 131 | Muscle Spasms | 83 | 2.0 | 2.1 | signal |
| 132 | Lymphoma | 7 | 2.0 | 2.0 | no signal |
| 133 | Hot Flush | 34 | 2.0 | 2.0 | signal |
| 134 | Therapeutic Product Effect Decreased | 20 | 2.0 | 2.0 | signal |
| 135 | Nerve Injury | 5 | 2.0 | 2.0 | no signal |
| 136 | Adverse Drug Reaction | 40 | 2.0 | 2.0 | signal |
| 137 | Cyanosis | 7 | 2.0 | 2.0 | no signal |
| 138 | Blindness | 18 | 2.0 | 2.0 | no signal |
| 139 | Hyperhidrosis | 57 | 2.0 | 2.0 | no signal |
| 140 | Status Epilepticus | 5 | 2.0 | 2.0 | no signal |
| 141 | Sensory Disturbance | 7 | 2.0 | 2.0 | no signal |
| 142 | Muscle Twitching | 10 | 2.0 | 2.0 | no signal |
| 143 | Memory Impairment | 59 | 1.9 | 1.9 | no signal |
| 144 | Incorrect Dose Administered | 96 | 1.9 | 1.9 | no signal |
| 145 | Blindness Unilateral | 6 | 1.9 | 1.9 | no signal |
| 146 | Caesarean Section | 5 | 1.9 | 1.9 | no signal |
| 147 | Covid-19 Pneumonia | 5 | 1.9 | 1.9 | no signal |
| 148 | Accident | 5 | 1.9 | 1.9 | no signal |
| 149 | Macular Degeneration | 5 | 1.9 | 1.9 | no signal |
| 150 | Hypokinesia | 6 | 1.9 | 1.9 | no signal |
| 151 | Underdose | 30 | 1.9 | 1.9 | no signal |
| 152 | Pruritus Generalised | 9 | 1.9 | 1.9 | no signal |
| 153 | Jaundice | 11 | 1.8 | 1.8 | no signal |
| 154 | Device Breakage | 16 | 1.8 | 1.8 | no signal |
| 155 | Cyst | 5 | 1.8 | 1.8 | no signal |
| 156 | Pneumocystis Jirovecii Pneumonia | 4 | 1.8 | 1.8 | no signal |
| 157 | Ovarian Cyst | 4 | 1.8 | 1.8 | no signal |
| 158 | Feeling Abnormal | 95 | 1.8 | 1.8 | no signal |
| 159 | Herpes Zoster | 22 | 1.7 | 1.7 | no signal |
| 160 | Skin Cancer | 8 | 1.7 | 1.7 | no signal |
| 161 | Mental Impairment | 9 | 1.7 | 1.7 | no signal |
| 162 | Generalised Tonic-clonic Seizure | 6 | 1.7 | 1.7 | no signal |
| 163 | Musculoskeletal Disorder | 7 | 1.7 | 1.7 | no signal |
| 164 | Cerebral Haemorrhage | 13 | 1.6 | 1.6 | no signal |
| 165 | Hyperthyroidism | 5 | 1.6 | 1.6 | no signal |
| 166 | Incorrect Product Administration Duration | 7 | 1.6 | 1.6 | no signal |
| 167 | Neoplasm Malignant | 23 | 1.6 | 1.6 | no signal |
| 168 | Product Prescribing Issue | 7 | 1.6 | 1.6 | no signal |
| 169 | Knee Arthroplasty | 7 | 1.5 | 1.5 | no signal |
| 170 | Product Dose Omission In Error | 9 | 1.5 | 1.5 | no signal |
| 171 | Spinal Operation | 4 | 1.5 | 1.5 | no signal |
| 172 | Thyroid Cancer | 4 | 1.5 | 1.5 | no signal |
| 173 | Foetal Exposure During Pregnancy | 26 | 1.4 | 1.4 | no signal |
| 174 | Increased Appetite | 6 | 1.4 | 1.4 | no signal |
| 175 | Premature Delivery | 5 | 1.4 | 1.4 | no signal |
| 176 | Decreased Immune Responsiveness | 3 | 1.4 | 1.4 | no signal |
| 177 | Inflammatory Bowel Disease | 3 | 1.4 | 1.4 | no signal |
| 178 | Drug Exposure During Pregnancy | 10 | 1.3 | 1.3 | no signal |
| 179 | Drug Effect Less Than Expected | 4 | 1.3 | 1.3 | no signal |
| 180 | Skin Irritation | 13 | 1.3 | 1.3 | no signal |
| 181 | Device Malfunction | 19 | 1.3 | 1.3 | no signal |
| 182 | Product Dispensing Error | 6 | 1.2 | 1.2 | no signal |
| 183 | Product Administered At Inappropriate Site | 5 | 1.2 | 1.2 | no signal |
| 184 | Product Availability Issue | 6 | 1.2 | 1.2 | no signal |
| 185 | Product Storage Error | 20 | 1.0 | 1.0 | no signal |
| 186 | Device Delivery System Issue | 6 | 1.0 | 1.0 | no signal |
| 187 | Dysmenorrhoea | 3 | 1.0 | 1.0 | no signal |
| 188 | Colitis Ulcerative | 10 | 1.0 | 1.0 | no signal |
| 189 | Menorrhagia | 4 | 0.9 | 0.9 | no signal |
| 190 | Wrong Technique In Device Usage Process | 9 | 0.9 | 0.9 | no signal |
| 191 | Amenorrhoea | 3 | 0.8 | 0.8 | no signal |
| 192 | Circumstance Or Information Capable Of Leading To Medication Error | 6 | 0.8 | 0.8 | no signal |
| 193 | Accidental Exposure To Product | 17 | 0.8 | 0.8 | no signal |
| 194 | Breast Cancer | 15 | 0.7 | 0.7 | no signal |
| 195 | Device Use Error | 4 | 0.5 | 0.5 | no signal |
| 196 | Menstruation Irregular | 3 | 0.5 | 0.5 | no signal |
| 197 | Incorrect Route Of Drug Administration | 4 | 0.5 | 0.5 | no signal |
| 198 | Drug Dose Omission By Device | 8 | 0.5 | 0.5 | no signal |
| 199 | Renal Cancer | 3 | 0.3 | 0.3 | no signal |